Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

161 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Optimal dosage regimen of meropenem for pediatric patients based on pharmacokinetic/pharmacodynamic considerations.
Ohata Y, Tomita Y, Nakayama M, Kozuki T, Sunakawa K, Tanigawara Y. Ohata Y, et al. Among authors: tanigawara y. Drug Metab Pharmacokinet. 2011;26(5):523-31. doi: 10.2133/dmpk.dmpk-11-rg-027. Epub 2011 Jul 12. Drug Metab Pharmacokinet. 2011. PMID: 21747200 Clinical Trial.
Predictive performance of the Bayesian analysis: effects of blood sampling time, population parameters, and pharmacostatistical model.
Tanigawara Y, Yano I, Kawakatsu K, Nishimura K, Yasuhara M, Hori R. Tanigawara Y, et al. J Pharmacokinet Biopharm. 1994 Feb;22(1):59-71. doi: 10.1007/BF02353410. J Pharmacokinet Biopharm. 1994. PMID: 8027949
Effect of its demethylated metabolite on the pharmacokinetics of unchanged TAK-603, a new antirheumatic agent, in rats.
Tagawa Y, Miwa K, Tsukuda R, Yoshimura Y, Tanayama S, Tanigawara Y. Tagawa Y, et al. Among authors: tanigawara y. Drug Metab Dispos. 1999 Apr;27(4):495-501. Drug Metab Dispos. 1999. PMID: 10101145
Population pharmacokinetic modeling and model validation of a spicamycin derivative, KRN5500, in phase 1 study.
Takama H, Tanaka H, Sudo T, Tamura T, Tanigawara Y. Takama H, et al. Among authors: tanigawara y. Cancer Chemother Pharmacol. 2001 May;47(5):404-10. doi: 10.1007/s002800000257. Cancer Chemother Pharmacol. 2001. PMID: 11391855 Clinical Trial.
Phase I and pharmacokinetic study of KRN5500, a spicamycin derivative, for patients with advanced solid tumors.
Yamamoto N, Tamura T, Kamiya Y, Ono H, Kondoh H, Shirao K, Matsumura Y, Tanigawara Y, Shimada Y. Yamamoto N, et al. Among authors: tanigawara y. Jpn J Clin Oncol. 2003 Jun;33(6):302-8. doi: 10.1093/jjco/hyg051. Jpn J Clin Oncol. 2003. PMID: 12913085 Clinical Trial.
Comparison of the pharmacokinetics of S-1, an oral anticancer agent, in Western and Japanese patients.
Comets E, Ikeda K, Hoff P, Fumoleau P, Wanders J, Tanigawara Y. Comets E, et al. Among authors: tanigawara y. J Pharmacokinet Pharmacodyn. 2003 Aug;30(4):257-83. doi: 10.1023/a:1026142601822. J Pharmacokinet Pharmacodyn. 2003. PMID: 14650374 Free PMC article.
Pharmacokinetic comparison of an angiotensin II receptor antagonist, telmisartan, in Japanese and western hypertensive patients using population pharmacokinetic method.
Tatami S, Yamamura N, Sarashina A, Yong CL, Igarashi T, Tanigawara Y. Tatami S, et al. Among authors: tanigawara y. Drug Metab Pharmacokinet. 2004 Feb;19(1):15-23. doi: 10.2133/dmpk.19.15. Drug Metab Pharmacokinet. 2004. PMID: 15499165
Relationship between pharmacokinetic parameters and occurrence of adverse events in clinical trials performed in Europe and United States for an angiotensin II receptor antagonist, telmisartan.
Tatami S, Sarashina A, Yamamura N, Igarashi T, Tanigawara Y. Tatami S, et al. Among authors: tanigawara y. Drug Metab Pharmacokinet. 2004 Feb;19(1):24-32. doi: 10.2133/dmpk.19.24. Drug Metab Pharmacokinet. 2004. PMID: 15499166
Population pharmacokinetics of an angiotensin II receptor antagonist, telmisartan, in healthy volunteers and hypertensive patients.
Tatami S, Sarashina A, Yamamura N, Igarashi T, Tanigawara Y. Tatami S, et al. Among authors: tanigawara y. Drug Metab Pharmacokinet. 2003;18(3):203-11. doi: 10.2133/dmpk.18.203. Drug Metab Pharmacokinet. 2003. PMID: 15618736
Linear pharmacokinetics of micafungin and its active metabolites in Japanese pediatric patients with fungal infections.
Tabata K, Katashima M, Kawamura A, Tanigawara Y, Sunagawa K. Tabata K, et al. Among authors: tanigawara y. Biol Pharm Bull. 2006 Aug;29(8):1706-11. doi: 10.1248/bpb.29.1706. Biol Pharm Bull. 2006. PMID: 16880629
161 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page